论文部分内容阅读
近一年来笔者在临床应用北京百奥药业有限责任公司的产品“百奥—蚓激酶胶囊”治疗脑梗塞取得满意的疗效。现报道如下: 1 对象和方法 1.1 选择确诊病例 全部患者30例均系住院病人,发病在24小时以内,意识清楚,无吞咽困难,均经头颅CT证实为脑梗塞。其中男性19例,年龄43岁到73岁,平均年龄56.7岁;女性11例,年龄49岁到?5岁,平均年龄60.3岁。30例患者平均年龄58.9岁。 1.2 治疗方法 1.2.1 从发病日起给予百奥—蚓激酶胶囊一次二粒,一日三次,饭前半小时服用,连续用15天。
In the past year, the author has achieved satisfactory results in the clinical treatment of cerebral infarction by using the product “Baoxiao-Lumbukinase Capsule” in the clinical application of Beijing Bio-Pharmaceutical Co., Ltd. Are reported as follows: 1 Subjects and methods 1.1 Select the confirmed cases All 30 patients were hospitalized patients, the incidence of less than 24 hours, a clear sense of consciousness, no swallowing difficulties, were confirmed by cerebral CT cerebral infarction. Including 19 males, aged 43 to 73 years old, with an average age of 56.7 years; 11 females, aged 49 to 5 years old, with an average age of 60.3 years. The average age of 30 patients was 58.9 years. 1.2 Treatment 1.2.1 given from the onset date Baiao - lumbrokinase capsules once two, three times a day, taking half an hour before meals, for 15 days.